{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:37:36Z","timestamp":1789137456558,"version":"build-2803163510"},"reference-count":28,"publisher":"IMR Press","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center, Poland","award":["2017\/25\/N\/NZ2\/00812"],"award-info":[{"award-number":["2017\/25\/N\/NZ2\/00812"]}]},{"name":"National Science Center, Poland","award":["2020\/37\/B\/NZ2\/01050"],"award-info":[{"award-number":["2020\/37\/B\/NZ2\/01050"]}]},{"name":"START scholarship from Foundation for Polish Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:Huntington\u2019s disease (HD) is an inherited (autosomal dominant) disorder caused by the occurrence of a pathogenic variant of the HTT gene. The genetic defect consists of an expansion of CAG repeats in exon 1, resulting in the production of a toxic misfolded huntingtin protein that forms aggregates. Currently, there is no registered therapy for this severe, neurodegenerative disease. Recent studies have demonstrated that treatment with genistein (4\u2032,5,7-trihydroxyisoflavone or 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one), which acts by stimulating autophagy through a FOXO3-dependent process, can ameliorate behavioral abnormalities and improve biochemical parameters in the R6\/1 mouse model of HD. However, although HD occurs in humans with similar frequency in men and women, the effects of high dose (150 mg\/kg\/day) of genistein on HD mice were tested previously only in males, because of concerns regarding potential ambiguity in interpretation of the results caused by structural similarities between genistein and estrogens. Nevertheless, as potential anti-HD therapies should be evaluated in both sexes, in this work the effects of genistein administration on behavior, levels of selected hormones, and biochemical parameters were evaluated in R6\/1 female mice.Methods:Several behavioral tests, including the Rota-rod test, elevated-plus maze, open field test, and Morris water maze, were performed using R6\/1 (HD) and control female mice treated with or without genistein at 150 mg\/kg\/day. We determined the levels of selected hormones and biochemical parameters in these animal groups. Genistein treatment was initiated at 16 weeks of age, shortly after the onset of symptoms at 14 weeks of age, and tests were conducted at 16, 22, and 30 weeks of age.Results:Genistein was effective in improving behavioral outcomes (p &lt; 0.05 for all tests vs untreated animals) and improving hormonal and biochemical parameters (p &lt; 0.05 for all tests) in female R6\/1 (HD), similarly to results reported previously for males of the same line.Conclusion:Genistein effectively reduced symptoms of HD in both male and female R6\/1 mice.<\/jats:p>","DOI":"10.31083\/fbl51780","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:50:51Z","timestamp":1783421451000},"source":"Crossref","is-referenced-by-count":1,"title":["Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) Is Effective in Reducing Symptoms of Huntington\u2019s Disease in Females of the R6\/1 Mouse Model"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-7204","authenticated-orcid":true,"given":"Lidia","family":"Gaffke","sequence":"first","affiliation":[{"name":"Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-766X","authenticated-orcid":true,"given":"Estera","family":"Rintz","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-618X","authenticated-orcid":true,"given":"Dorota","family":"My\u015bli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-5955","authenticated-orcid":true,"given":"Magdalena","family":"Podlacha","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-6567","authenticated-orcid":true,"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":true,"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C. Huntington disease: Advances in the understanding of its mechanisms. Clinical parkinsonism & related disorders. 2020; 3: 100056.","DOI":"10.1016\/j.prdoa.2020.100056"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Vega AJ, Hernandez GV, O'Malley PA, Robin CJ, Parra AN, Varrassi G, et al. Overview of Huntington's disease and emerging treatment strategies: A narrative review. Cureus. 2025; 17: e98243.","DOI":"10.7759\/cureus.98243"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Handsaker RE, Kashin S, Reed NM, Tan S, Lee WS, McDonald TM, et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease. Cell. 2025; 188: 623\u2013639.e19.","DOI":"10.1016\/j.cell.2024.11.038"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Scahill RI, Farag M, Murphy MJ, Hobbs NZ, Leocadi M, Langley C, et al. Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis. Nature Medicine. 2025; 31: 807\u2013818.","DOI":"10.1038\/s41591-024-03424-6"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Masna H, Konda M, Ganti L. Huntington's Disease Research Over Six Decades: Global Insights, Gaps, and Future Directions. Cureus. 2025; 17: e97567.","DOI":"10.7759\/cureus.97567"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ravikumar B, Duden R, Rubinsztein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Human Molecular Genetics. 2002; 11: 1107\u20131117.","DOI":"10.1093\/hmg\/11.9.1107"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genetics. 2004; 36: 585\u2013595.","DOI":"10.1038\/ng1362"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Cui M, Yoshimori T, Nakamura S. Autophagy system as a potential therapeutic target for neurodegenerative diseases. Neurochemistry International. 2022; 155: 105308.","DOI":"10.1016\/j.neuint.2022.105308"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Engelender S, Stefanis L, Oddo S, Bellucci A. Can we treat neurodegenerative proteinopathies by enhancing protein degradation?. Movement Disorders. 2022; 37: 1346\u20131359.","DOI":"10.1002\/mds.29058"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Pierzynowska K, Gaffke L, Cyske Z, Puchalski M, Rintz E, Bartkowski M, et al. Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases. Metabolic Brain Disease. 2018; 33: 989\u20131008.","DOI":"10.1007\/s11011-018-0214-6"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Pierzynowska K, Gaffke L, Ha\u0107 A, Mantej J, Niedzia\u0142ek N, Brokowska J, et al. Correction of Huntington's disease phenotype by genistein-induced autophagy in the cellular model. Neuromolecular Medicine. 2018; 20: 112\u2013123.","DOI":"10.1007\/s12017-018-8482-1"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Pierzynowska K, Gaffke L, Cyske Z, W\u0119grzyn G. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients. Metabolic Brain Disease. 2019; 34: 715\u2013720.","DOI":"10.1007\/s11011-019-00405-4"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Shimazu R, Anada M, Miyaguchi A, Nomi Y, Matsumoto H. Evaluation of Blood-Brain Barrier Permeability of Polyphenols, Anthocyanins, and Their Metabolites. Journal of Agricultural and Food Chemistry. 2021; 69: 11676\u201311686.","DOI":"10.1021\/acs.jafc.1c02898"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim KH, Dodsworth C, Paras A, Burton BK. High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system. Molecular Genetics and Metabolism. 2013; 109: 382\u2013385.","DOI":"10.1016\/j.ymgme.2013.06.012"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Pierzynowska K, Podlacha M, Gaffke L, Rintz E, Wi\u015bniewska K, Cyske Z, et al. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation. Autophagy. 2024; 20: 1159\u20131182.","DOI":"10.1080\/15548627.2023.2286116"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996; 87: 493\u2013506.","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Podlacha M, Pierzynowska K, Gaffke L, Jerzemowska G, Piotrowska E, W\u0119grzyn G. Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease. Brain, Behavior, & Immunity-Health. 2022; 23: 100482.","DOI":"10.1016\/j.bbih.2022.100482"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Intharuksa A, Arunotayanun W, Na Takuathung M, Chaichit S, Prasansuklab A, Chaikhong K, et al. Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy. International Journal of Molecular Sciences. 2025; 26: 6973.","DOI":"10.3390\/ijms26146973"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Dowie MJ, Howard ML, Nicholson LFB, Faull RLM, Hannan AJ, Glass M. Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice. Neuroscience. 2010; 170: 324\u2013336.","DOI":"10.1016\/j.neuroscience.2010.06.056"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Saavedra A, Giralt A, Arum\u00ed H, Alberch J, P\u00e9rez-Navarro E. Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease. PloS One. 2013; 8: e73664.","DOI":"10.1371\/journal.pone.0073664"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Malinowska M, Wilkinson FL, Bennett W, Langford-Smith KJ, O'Leary HA, Jakobkiewicz-Banecka J, et al. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Molecular Genetics and Metabolism. 2009; 98: 235\u2013242.","DOI":"10.1016\/j.ymgme.2009.06.013"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Malinowska M, Wilkinson FL, Langford-Smith KJ, Langford-Smith A, Brown JR, Crawford BE, et al. Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS On. 2010; 5: e14192.","DOI":"10.1371\/journal.pone.0014192"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ghosh A, Rust S, Langford-Smith K, Weisberg D, Canal M, Breen C, et al. High dose genistein in Sanfilippo syndrome: A randomised controlled trial. Journal of Inherited Metabolic Disease. 2021; 44: 1248\u20131262.","DOI":"10.1002\/jimd.12407"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Jindal A, Rai SN. Targeting Autophagy, Ferroptosis, and Neuroinflammation: Polyphenol-Mediated Modulation of Emerging Signaling Pathways in Neurodegeneration. Molecular Neurobiology. 2026; 63: 470.","DOI":"10.1007\/s12035-026-05760-9"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Rai SN (ed.) Vitamins and Neurodegeneration: Mechanisms and Therapeutic Insights. CRC Press: Boca Raton, FL, USA. 2026.","DOI":"10.1201\/9781003686675"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Renoir T, Pang TY, Shikano Y, Li S, Hannan AJ. Loss of the sexually dimorphic neuro-inflammatory response in a transgenic mouse model of Huntington's disease. Journal of Huntington's Disease. 2015; 4: 297\u2013303.","DOI":"10.3233\/JHD-150153"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zhou S, Wang X, Wang YT. 3D-AI mouse behavior analysis system has the capability to detect abnormalities in R6\/1 model mice with Huntington's disease during the pre-symptomatic phase. Frontiers in Psychiatry. 2026; 17: 1749543.","DOI":"10.3389\/fpsyt.2026.1749543"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Ruberte J, Schofield PN, Sundberg JP, Rodriguez-Baeza A, Carretero A, McKerlie C. Bridging mouse and human anatomies; a knowledge-based approach to comparative anatomy for disease model phenotyping. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 2023; 34: 389\u2013407.","DOI":"10.1007\/s00335-023-10005-4"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL51780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:51:08Z","timestamp":1783421468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL51780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02150-7"],"URL":"https:\/\/doi.org\/10.31083\/fbl51780","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"51780"}}